Cargando…

Patient-Reported Outcome in Two Chronic Diseases: A Comparison of Quality of Life and Response Profiles in Severe Migraine and Severe Asthma

INTRODUCTION: Migraine and asthma are two frequent, disabling, chronic disorders with a major impact on patient well-being. The objectives of this study were to compare subjective well-being between patients with severe forms of migraine or asthma using a panel of PROs. METHODS: Adult patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucas, Christian, Aly, Samia, Touboul, Chantal, Sellami, Rahma, Guillaume, Xavier, Garcia, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012635/
https://www.ncbi.nlm.nih.gov/pubmed/32104124
http://dx.doi.org/10.2147/PROM.S222597
_version_ 1783496262118539264
author Lucas, Christian
Aly, Samia
Touboul, Chantal
Sellami, Rahma
Guillaume, Xavier
Garcia, Gilles
author_facet Lucas, Christian
Aly, Samia
Touboul, Chantal
Sellami, Rahma
Guillaume, Xavier
Garcia, Gilles
author_sort Lucas, Christian
collection PubMed
description INTRODUCTION: Migraine and asthma are two frequent, disabling, chronic disorders with a major impact on patient well-being. The objectives of this study were to compare subjective well-being between patients with severe forms of migraine or asthma using a panel of PROs. METHODS: Adult patients were recruited during routine consultations with chest physicians or neurologists. Patients with severe migraine (reporting headaches on ≥8 days/month and having failed ≥2 prophylactic treatments) and patients with severe asthma (according to the 2017 GINA definition: requiring Step 4 or 5 treatment or presenting uncontrolled symptoms) were eligible. Each patient completed the EuroQol Questionnaire (EQ-5D-5L), the Work Productivity and Activity Impairment Questionnaire (WPAI) and the Hospital Anxiety and Depression scale (HAD). Patients with severe migraine the 6-item Headache Impact Test (HIT-6) and those with severe asthma completed the Asthma Control Test (ACT). RESULTS: 249 patients with severe migraine and 96 with severe asthma were enrolled. Mean EQ-5D-5L utility scores were significantly higher in the severe migraine group than in the severe asthma group (0.75±0.25 vs 0.68±0.26; p<0.01). Low EQ-5D-5L utility scores were associated with frequent (≥15 headache days/month) or disabling (HIT-6 score ≥60) headaches and with poor asthma control. Patients with severe migraine more frequently presented a HAD depression score ≥11 (23.0% in severe migraine; 7.5% in severe asthma; p<0.01), whereas those with severe asthma more frequently reported problems with mobility, self-care and usual activities. Absenteeism (percent worktime missed) was similar in both groups (severe migraine: 9.0%±19.1%; severe asthma: 13.8%±22.9%) but work impairment was higher in the severe migraine group (44.3% vs 28.4%; p<0.01). CONCLUSION: Quality of life, work activity and psychological distress are all deteriorated in both severe migraine and severe asthma. Different aspects are affected in the two diseases: a greater impact on psychological aspects in severe migraine and a greater impact on physical aspects in severe asthma.
format Online
Article
Text
id pubmed-7012635
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-70126352020-02-26 Patient-Reported Outcome in Two Chronic Diseases: A Comparison of Quality of Life and Response Profiles in Severe Migraine and Severe Asthma Lucas, Christian Aly, Samia Touboul, Chantal Sellami, Rahma Guillaume, Xavier Garcia, Gilles Patient Relat Outcome Meas Original Research INTRODUCTION: Migraine and asthma are two frequent, disabling, chronic disorders with a major impact on patient well-being. The objectives of this study were to compare subjective well-being between patients with severe forms of migraine or asthma using a panel of PROs. METHODS: Adult patients were recruited during routine consultations with chest physicians or neurologists. Patients with severe migraine (reporting headaches on ≥8 days/month and having failed ≥2 prophylactic treatments) and patients with severe asthma (according to the 2017 GINA definition: requiring Step 4 or 5 treatment or presenting uncontrolled symptoms) were eligible. Each patient completed the EuroQol Questionnaire (EQ-5D-5L), the Work Productivity and Activity Impairment Questionnaire (WPAI) and the Hospital Anxiety and Depression scale (HAD). Patients with severe migraine the 6-item Headache Impact Test (HIT-6) and those with severe asthma completed the Asthma Control Test (ACT). RESULTS: 249 patients with severe migraine and 96 with severe asthma were enrolled. Mean EQ-5D-5L utility scores were significantly higher in the severe migraine group than in the severe asthma group (0.75±0.25 vs 0.68±0.26; p<0.01). Low EQ-5D-5L utility scores were associated with frequent (≥15 headache days/month) or disabling (HIT-6 score ≥60) headaches and with poor asthma control. Patients with severe migraine more frequently presented a HAD depression score ≥11 (23.0% in severe migraine; 7.5% in severe asthma; p<0.01), whereas those with severe asthma more frequently reported problems with mobility, self-care and usual activities. Absenteeism (percent worktime missed) was similar in both groups (severe migraine: 9.0%±19.1%; severe asthma: 13.8%±22.9%) but work impairment was higher in the severe migraine group (44.3% vs 28.4%; p<0.01). CONCLUSION: Quality of life, work activity and psychological distress are all deteriorated in both severe migraine and severe asthma. Different aspects are affected in the two diseases: a greater impact on psychological aspects in severe migraine and a greater impact on physical aspects in severe asthma. Dove 2020-02-07 /pmc/articles/PMC7012635/ /pubmed/32104124 http://dx.doi.org/10.2147/PROM.S222597 Text en © 2020 Lucas et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Lucas, Christian
Aly, Samia
Touboul, Chantal
Sellami, Rahma
Guillaume, Xavier
Garcia, Gilles
Patient-Reported Outcome in Two Chronic Diseases: A Comparison of Quality of Life and Response Profiles in Severe Migraine and Severe Asthma
title Patient-Reported Outcome in Two Chronic Diseases: A Comparison of Quality of Life and Response Profiles in Severe Migraine and Severe Asthma
title_full Patient-Reported Outcome in Two Chronic Diseases: A Comparison of Quality of Life and Response Profiles in Severe Migraine and Severe Asthma
title_fullStr Patient-Reported Outcome in Two Chronic Diseases: A Comparison of Quality of Life and Response Profiles in Severe Migraine and Severe Asthma
title_full_unstemmed Patient-Reported Outcome in Two Chronic Diseases: A Comparison of Quality of Life and Response Profiles in Severe Migraine and Severe Asthma
title_short Patient-Reported Outcome in Two Chronic Diseases: A Comparison of Quality of Life and Response Profiles in Severe Migraine and Severe Asthma
title_sort patient-reported outcome in two chronic diseases: a comparison of quality of life and response profiles in severe migraine and severe asthma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012635/
https://www.ncbi.nlm.nih.gov/pubmed/32104124
http://dx.doi.org/10.2147/PROM.S222597
work_keys_str_mv AT lucaschristian patientreportedoutcomeintwochronicdiseasesacomparisonofqualityoflifeandresponseprofilesinseveremigraineandsevereasthma
AT alysamia patientreportedoutcomeintwochronicdiseasesacomparisonofqualityoflifeandresponseprofilesinseveremigraineandsevereasthma
AT touboulchantal patientreportedoutcomeintwochronicdiseasesacomparisonofqualityoflifeandresponseprofilesinseveremigraineandsevereasthma
AT sellamirahma patientreportedoutcomeintwochronicdiseasesacomparisonofqualityoflifeandresponseprofilesinseveremigraineandsevereasthma
AT guillaumexavier patientreportedoutcomeintwochronicdiseasesacomparisonofqualityoflifeandresponseprofilesinseveremigraineandsevereasthma
AT garciagilles patientreportedoutcomeintwochronicdiseasesacomparisonofqualityoflifeandresponseprofilesinseveremigraineandsevereasthma